WuXi Chemistry

Oligonucleotide conjugates demand precise purification to achieve high purity and yield, challenges that can significantly impact your development timelines and project success. At WuXi TIDES, we excel in overcoming these challenges with WuXi Speed and flexibility. Leveraging state-of-the-art technology and a team of experts, we provide customized purification solutions that not only enhance purity and yield but also ensure your projects progress on schedule, meeting all quality and regulatory standards. Learn more: https://lnkd.in/esWPCP4N #Oligonucleotides #Conjugates #Purification #DrugDevelopment #WuXiTIDES #CRDMO

Join WuXi STA at Booth 17 at Formulation & Delivery 2024 in San Diego this week! Our Drug Product Platform offers end-to-end formulation development and manufacturing solutions for both oral solids and parenterals. With a suite of advanced bioavailability enhancement technologies, we tackle complex solubility and delivery challenges. Backed by a dual supply chain across Asia and Europe, we ensure reliable, flexible solutions tailored to your project needs. Learn more: https://lnkd.in/eTxsZr6W #FormulationAndDelivery #DrugDevelopment #Bioavailability #CMC #WuXiSTA

WuXi TIDES Catalog Products recently added 100 new amidite products to the portfolio. Now, WuXi TIDES offers over 600 catalog amidite products for direct purchase online. Be the first to learn more about additions to our portfolio and receive a structure-data file (SDF) of our portfolio by subscribing for new product updates today. Sign up on our home page and register for an account to shop all WuXi TIDES Catalog Products: https://lnkd.in/exwmTMhx #Amidites #CatalogProducts #Oligonucleotides #Synthesis #DrugDiscovery #WuXiTIDES #CRDMO

We’re excited to announce the latest enhancement to our Early Intermediates manufacturing facility in Changshu, China: a new enzyme fermentation plant that strengthens our #biocatalysis capabilities. This expansion increases our total enzyme fermentation capacity to 22,850 L, allowing us to better meet your project’s unique needs by offering greater scalability, speed, and efficiency. WuXi STA’s Biocatalysis Technology Platform provides comprehensive solutions, from enzyme screening, enzyme evolution and enzyme production to biocatalytic process development and production. With over 2,500 library enzymes and expertise in 25+ reaction types, we’re here to ensure your projects move forward with confidence and success. In 2023, we applied biocatalysis across 60 synthetic steps, producing over 90 metric tons of APIs and intermediates, helping our partners bring treatments to market faster and more sustainably. 🔗 Discover how our enzyme screening and evolution lowered synthetic costs in this case study: https://lnkd.in/esaWRgdc

Thank you for joining WuXi STA and WuXi TIDES at #CPHIMilan 2024! We had an incredible time connecting with so many longtime friends and meeting with industry experts. Your enthusiasm and engagement made this year’s event truly unforgettable. Over the past few days, we discussed how our comprehensive CRDMO services can support projects from early development through commercialization. Whether you’re focused on small molecules, oligonucleotides, peptides, or complex conjugates, our global team is committed to helping streamline your drug development journey. Missed us at the event? Reach out to learn more about how we can support your next project https://lnkd.in/esJjxutd

Visit WuXi STA at Booth 1730 during the AAPS 2024 in Salt Lake City from Oct. 20-23! Explore how our integrated CMC services can streamline your drug development journey with WuXi Speed. From drug substance to drug product development, whether oral solids or sterile injectables, we specialize in all synthetic molecules, including small molecules, oligonucleotides, peptides, and their complex conjugates. Plus, don’t miss our Happy Hour on Oct. 22, from 3:00–4:00 PM at our booth! Come for a drink, network with formulation experts, and discover how we can support your projects! Planning to attend? Pre-schedule a meeting with us: https://lnkd.in/e_FcU25b

Join WuXi STA at Booth 17 at Formulation & Delivery 2024, October 16-17, in San Diego. Our Drug Product Platform provides end-to-end formulation development and manufacturing solutions for both oral solids and parenterals. With a suite of advanced bioavailability enhancement technologies, we tackle complex solubility and delivery challenges. Backed by a dual supply chain across Asia and Europe, we ensure reliable, flexible solutions tailored to your project needs. Schedule a meeting with us to learn more: STA_info@wuxiapptec.com #FormulationAndDelivery #DrugDevelopment #Bioavailability #CMC

#CPHI Worldwide 2024 in Milan is officially underway! Our WuXi STA and WuXi TIDES teams are on-site at Booth 2B18 in the API Hall, ready to connect with you. From small molecule drug substances to advanced oligonucleotide and peptide solutions, we’re here to discuss how our integrated CRDMO services can support your project’s success—whether you’re in early development or nearing commercialization. Take this opportunity to meet our global team and discover how we can accelerate your pharmaceutical development journey with WuXi Speed. #CPHI2024 #CRDMO #CMC #WuXiSTA #WuXiTIDES

The energy is high at the Oligonucleotide Therapeutics Society 2024 in Montreal! Our WuXi TIDES team is excited to connect with you at Booth 4-1 and discuss how our comprehensive oligonucleotide CRDMO platform can support your projects from discovery through commercial manufacturing. Whether you’re advancing ASOs, siRNAs, PMOs, or complex oligonucleotide conjugates, we provide the expertise and tailored solutions to support your projects, at any stage and scale. Looking for high-quality amidite building blocks? Explore our TIDES Catalog (https://lnkd.in/exwmTMhx) and accelerate your oligonucleotide synthesis with WuXi Speed. #OTS2024 #oligonucleotides #siRNA #WuXiTIDES #CRDMO